FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2329602178> ?p ?o ?g. }

• W2329602178 endingPage "A38" @default.
• W2329602178 startingPage "A37.3" @default.
• W2329602178 abstract "<h3>Background</h3> Current guidelines at MMUH for the antimicrobial treatment of febrile neutropenia are based on an escalation approach as recommended by the Infectious Diseases Society of America (IDSA) and European Conference on Infections in Leukaemia 3 (ECIL3). Piperacillin/tazobactam in combination with ciprofloxacin or gentamicin are the empiric agents recommended in the current MMUH guidelines. In 2009, a retrospective audit of positive blood cultures from 2006–2008 in MMUH haematology patients with febrile neutropenia was used to assess the appropriateness of the guidelines in use at that time. These guidelines were amended following completion of the audit. With global and national concerns regarding increasing resistance in Gram-negative organisms and considering the new de-escalation approach recently discussed at ECIL4 it was decided to re-audit blood culture results in these patients and assess if any further changes to the local guidelines were necessary. <h3>Purpose</h3> To establish the appropriateness of local antimicrobial guidelines for the treatment of febrile neutropenia in MMUH patients. <h3>Materials and methods</h3> A retrospective review was undertaken of positive blood culture isolates in haematology patients from July 2009–June 2012. The laboratory information system (Telepath) identified haematology patients. Patients were excluded if they were not neutropenic within 48 h of the positive blood culture. The data collected included the organisms identified and their susceptibility patterns. The current guidelines were then reviewed for appropriateness and will be updated accordingly. <h3>Results</h3> An audit with two cycles (2006–2008 and 2009–2012) was completed. Some findings were consistent between the two cycles, e.g. higher bacteraemia rate among patients with profound neutropenia. Levels of susceptibility of Gram-negative organisms to the first-line agent piperacillin/tazobactam were between 79–92% which is reassuring. The main difference noted between the two cycles was a rising quinolone resistance rate to Gram-negative pathogens over time. <h3>Conclusions</h3> The MMUH guidelines for the antimicrobial treatment of febrile neutropenia require modification to reflect quinolone resistance. This re-audit reassures us that empiric piperacillin/tazobactam in combination with gentamicin remains a satisfactory first line treatment in these patients. Currently, there is no indication for such a radical approach as the de-escalation approach discussed at ECIL 4. No conflict of interest." @default.
• W2329602178 created "2016-06-24" @default.
• W2329602178 creator A5010029979 @default.
• W2329602178 creator A5011927731 @default.
• W2329602178 creator A5016327450 @default.
• W2329602178 creator A5032254923 @default.
• W2329602178 creator A5036083894 @default.
• W2329602178 creator A5054119627 @default.
• W2329602178 creator A5054973401 @default.
• W2329602178 creator A5073760158 @default.
• W2329602178 date "2014-02-24" @default.
• W2329602178 modified "2023-09-25" @default.
• W2329602178 title "CP-093 Escalation or de-escalation for the treatment of febrile neutropenia" @default.
• W2329602178 doi "https://doi.org/10.1136/ejhpharm-2013-000436.91" @default.
• W2329602178 hasPublicationYear "2014" @default.
• W2329602178 type Work @default.
• W2329602178 sameAs 2329602178 @default.
• W2329602178 citedByCount "0" @default.
• W2329602178 crossrefType "journal-article" @default.
• W2329602178 hasAuthorship W2329602178A5010029979 @default.
• W2329602178 hasAuthorship W2329602178A5011927731 @default.
• W2329602178 hasAuthorship W2329602178A5016327450 @default.
• W2329602178 hasAuthorship W2329602178A5032254923 @default.
• W2329602178 hasAuthorship W2329602178A5036083894 @default.
• W2329602178 hasAuthorship W2329602178A5054119627 @default.
• W2329602178 hasAuthorship W2329602178A5054973401 @default.
• W2329602178 hasAuthorship W2329602178A5073760158 @default.
• W2329602178 hasConcept C126322002 @default.
• W2329602178 hasConcept C142724271 @default.
• W2329602178 hasConcept C162324750 @default.
• W2329602178 hasConcept C167135981 @default.
• W2329602178 hasConcept C177713679 @default.
• W2329602178 hasConcept C187212893 @default.
• W2329602178 hasConcept C187736073 @default.
• W2329602178 hasConcept C194409129 @default.
• W2329602178 hasConcept C194828623 @default.
• W2329602178 hasConcept C199521495 @default.
• W2329602178 hasConcept C2776056953 @default.
• W2329602178 hasConcept C2776694085 @default.
• W2329602178 hasConcept C2777063308 @default.
• W2329602178 hasConcept C2777637488 @default.
• W2329602178 hasConcept C2777858937 @default.
• W2329602178 hasConcept C2778193466 @default.
• W2329602178 hasConcept C2778266534 @default.
• W2329602178 hasConcept C2778850193 @default.
• W2329602178 hasConcept C2779473907 @default.
• W2329602178 hasConcept C2780182762 @default.
• W2329602178 hasConcept C501593827 @default.
• W2329602178 hasConcept C523546767 @default.
• W2329602178 hasConcept C54355233 @default.
• W2329602178 hasConcept C71924100 @default.
• W2329602178 hasConcept C86803240 @default.
• W2329602178 hasConcept C89423630 @default.
• W2329602178 hasConceptScore W2329602178C126322002 @default.
• W2329602178 hasConceptScore W2329602178C142724271 @default.
• W2329602178 hasConceptScore W2329602178C162324750 @default.
• W2329602178 hasConceptScore W2329602178C167135981 @default.
• W2329602178 hasConceptScore W2329602178C177713679 @default.
• W2329602178 hasConceptScore W2329602178C187212893 @default.
• W2329602178 hasConceptScore W2329602178C187736073 @default.
• W2329602178 hasConceptScore W2329602178C194409129 @default.
• W2329602178 hasConceptScore W2329602178C194828623 @default.
• W2329602178 hasConceptScore W2329602178C199521495 @default.
• W2329602178 hasConceptScore W2329602178C2776056953 @default.
• W2329602178 hasConceptScore W2329602178C2776694085 @default.
• W2329602178 hasConceptScore W2329602178C2777063308 @default.
• W2329602178 hasConceptScore W2329602178C2777637488 @default.
• W2329602178 hasConceptScore W2329602178C2777858937 @default.
• W2329602178 hasConceptScore W2329602178C2778193466 @default.
• W2329602178 hasConceptScore W2329602178C2778266534 @default.
• W2329602178 hasConceptScore W2329602178C2778850193 @default.
• W2329602178 hasConceptScore W2329602178C2779473907 @default.
• W2329602178 hasConceptScore W2329602178C2780182762 @default.
• W2329602178 hasConceptScore W2329602178C501593827 @default.
• W2329602178 hasConceptScore W2329602178C523546767 @default.
• W2329602178 hasConceptScore W2329602178C54355233 @default.
• W2329602178 hasConceptScore W2329602178C71924100 @default.
• W2329602178 hasConceptScore W2329602178C86803240 @default.
• W2329602178 hasConceptScore W2329602178C89423630 @default.
• W2329602178 hasIssue "Suppl 1" @default.
• W2329602178 hasLocation W23296021781 @default.
• W2329602178 hasOpenAccess W2329602178 @default.
• W2329602178 hasPrimaryLocation W23296021781 @default.
• W2329602178 hasRelatedWork W1963731576 @default.
• W2329602178 hasRelatedWork W1974787197 @default.
• W2329602178 hasRelatedWork W1982667310 @default.
• W2329602178 hasRelatedWork W2036430026 @default.
• W2329602178 hasRelatedWork W2329602178 @default.
• W2329602178 hasRelatedWork W2735237349 @default.
• W2329602178 hasRelatedWork W3119408265 @default.
• W2329602178 hasRelatedWork W4307954419 @default.
• W2329602178 hasRelatedWork W4310866079 @default.
• W2329602178 hasRelatedWork W4312793288 @default.
• W2329602178 hasVolume "21" @default.
• W2329602178 isParatext "false" @default.
• W2329602178 isRetracted "false" @default.
• W2329602178 magId "2329602178" @default.
• W2329602178 workType "article" @default.